AT-rich DNA minor groove

The AT-rich DNA minor groove is a specific structural domain within the B-form DNA double helix, characterized by a narrow and deep geometry that is highly conducive to the binding of small, crescent-shaped molecules (PubMed: 22403100). These AT-rich regions are frequently located in regulatory sequences, such as promoters and origins of replication, where they play a vital role in the binding of transcription factors and the maintenance of chromatin architecture (Wikipedia: Minor groove binder). Therapeutic agents known as minor groove binders (MGBs) target these sites through a combination of hydrogen bonding, van der Waals forces, and electrostatic interactions (PubChem: Pentamidine). By binding to the minor groove, these drugs can effectively inhibit DNA-dependent processes, including replication and transcription, or interfere with the activity of enzymes like topoisomerases (PubMed: 15109563). Consequently, the AT-rich DNA minor groove serves as a significant target for the development of antimicrobial, antiparasitic, and anticancer therapies (NIH: Drug-DNA Interactions). Despite their potency, the clinical application of MGBs is often challenged by concerns regarding non-specific DNA binding and potential genotoxicity (PubMed: 11473353).

Other names

DNA minor grooveAT-rich DNAMinor groove of B-DNAAdenine-Thymine rich minor groove

Minor groove binders typically occupy the AT-rich regions of the DNA minor groove, displacing essential DNA-binding proteins such as transcription factors and architectural proteins. This binding can also inhibit the activity of DNA-modifying enzymes like topoisomerase II, leading to the induction of DNA strand breaks and the inhibition of replication and transcription (PubMed: 22403100, PubMed: 15109563).